Donate Register

Update on ALS TDI Drug Development Pipeline

We will provide a comprehensive review of our current drug development pipeline, including the latest information on:

TDI 846 (Biogen Idec and UCB Pharma effort)
TDI 132 (clinical trial on Gilenya in ALS patients)
Regensance Partnership
Neurotune Partnership
Other partnerships
TDP43 mouse model charectorization
etc

Panelists include:
Steve Perrin, Ph.D.
John Lincecum, Ph.D.
Fernando G. Vieira, M.D.

Thank you for your interest in viewing the Update on ALS TDI Drug Development Pipeline webinar!

Please provide the following information so that we can continue to make our Webinars relevant for the entire ALS community:

* = Required Fields

Contact Information First Name: * Last Name: * Email: * Confirm Email: Phone: * Street Address: City: * State/Region: * Zip: * Country: * I am... *

Verification Type the two words into the field below:

Submit

Find this useful?
Help us fund more science:

Donate

Webinars

All times are Eastern.

No Webinars Available

90 mins on Stem Cell Clinical Trials (Recorded 5/8/13)
Co-hosts: Rob Goldstein (TDI) & Dr. Yael Gothelf (BrainStorm) discuss current and future trials from Neuralstem, Brainstorm, Mayo Clinic, TCA Cellular, Q Therapeutics, Cedars Sinai, California Stem Cell, etc
Click here to watch archive

What's in the pipeline? (Recorded 4/11/13)
Drs. Lincecum, Perrin and Vieira from TDI provide the ALS patient and research community with an in-depth look into the current and emerging pipeline of potential therapeutics being investigated at the world's largest ALS research center.
Click here to watch archive

View all archives >